Cargando…
Pancreatic Endocrine Tumors: A Report on a Patient Treated with Sorafenib
A 31-yr-old man with abdominal pain was diagnosed with a pancreatic endocrine tumor and multiple hepatic metastases. Despite optimal treatment with interferon alpha, a somatostatin analog, local therapy with high-intensity focused ultrasound ablation for multiple hepatic metastases, and multiple lin...
Autores principales: | Jeong, Hee Kyoung, Roh, Sang Young, Hong, Sook Hee, Won, Hye Sung, Jeon, Eun Kyoung, Shin, Ok Ran, Lee, Su Lim, Ko, Yoon Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124729/ https://www.ncbi.nlm.nih.gov/pubmed/21738352 http://dx.doi.org/10.3346/jkms.2011.26.7.954 |
Ejemplares similares
-
Prognostic significance of CD44s expression in resected non-small cell lung cancer
por: Ko, Yoon Ho, et al.
Publicado: (2011) -
Modified FOLFIRI as Second-Line Chemotherapy after Failure of Modified FOLFOX-4 in Advanced Gastric Cancer
por: Jeon, Eun Kyoung, et al.
Publicado: (2011) -
Prognostic Significance of Nuclear Survivin Expression in Resected Adenoid Cystic Carcinoma of the Head and Neck
por: Ko, Yoon Ho, et al.
Publicado: (2010) -
Sorafenib Induces Delayed-Onset Cutaneous Hypersensitivity: A Case Series
por: Sohn, Kyoung-hee, et al.
Publicado: (2015) -
Bacterial extracellular vesicles affect endocrine therapy in MCF7 cells
por: An, Jeongshin, et al.
Publicado: (2021)